NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
07/03/2019
Voltar para busca
Dado oficial do USPTO
BEAUFORT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
BEAUFORT
ST13
US500000077600189Classe
35, 40, 42, 45
Pedido
77600189
Registro
3690806
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
33
Atualização mais recente
07/03/2019
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 40, 42, 45
Data de depósito
24/10/2008
Data de registro
29/09/2009
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
07/03/2019
Última transação
07/03/2019
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Supplemental Register
Fundamento do pedido
Intent to use
Primeiro uso
25/06/2009
Primeiro uso no comércio
25/06/2009
Código do desenho
4
Tipo de titular
16
Localização do titular
NORFOLK, VA, US
Examinador
GENOVESE,CARRIE A
Unidade examinadora
M60
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
BEAUFORT, LLC
Beaufort Advisors, LLC
Representantes
TIMOTHY J. LOCKHART WILLCOX & SAVAGE, P.C.
Classificação técnica
Classes Nice
Classe 35Classe 40Classe 42Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Regulatory submission managementassisting others in preparing Investigational New Drug applications (INDs) and New Drug Applications (NDAs) for submission to the FDA; database management
Classe 40
Consulting services in the field of manufacturing compliance and validationproviding technical advice related to the manufacture of pharmaceuticals
Classe 42
Contract research organization (CRO) servicesmonitoring of clinical trials for investigational drugs of biotech and pharmaceutical companiesclinical trial project management and quality assurancemedical writing of investigational drug protocolsmedical research in the nature of biostatistical analysis; consulting services in the field of conducting clinical trialsdrug developmentmanufacturing environmental compliance and validationadvanced technology in the pharmaceutical fieldmedical research in the nature of clinical benchmarking used to improve the performance of professionals in the fields of international healththe pharmaceutical industrythe biotechnology industry and the medical device and diagnostics industries; providing quality assurance services in the field of regulatory submissions to the FDA by life sciences companies to ensure validity and accuracy; product development for othersproviding implementation services relating to the development and validation of drugsdevices and biologics
Classe 45
Legal researchregulatory research in the pharmaceutical industrybiotechnology industry and the medical and diagnostics industry; consultation in the field of regulatory compliance to ensure validity and accuracy of regulatory submissions to the FDA by life sciences companies; conducting regulatory and compliance audits for othersreviewing standards and practices to assure compliance with laws and regulations in the fields of pharmaceuticalveterinarypharmacogenomicbiotechnical and medical products and devices; providing information relating to legal affairsproviding regulatory information relating to the development and validation of drugsdevices and biologics; regulatory compliance consulting as it applies to clinical trialsmonitoring by clinical research administrators for compliance with regulations governing clinical trials; legal document preparation servicespreparation of Investigational New Drug applications (INDs) and New Drug Applications (NDAs) for submission to the FDA; consulting services in the field of regulatory affairs and manufacturing compliance and validationregulatory compliance consulting as it applies to prescription drug sampling; consulting services in the field of clinical benchmarking and performance improvementproviding independent review of clinical trials involving human subjects in the nature of reviewing research protocols and related information to ensure protection of the rights and welfare of human subjects of research
Publicações
Histórico de despachos e eventos da marca no USPTO.
33 publicações encontradas
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
07/03/2019
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
07/03/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/03/2019
E89R
TEAS SECTION 8 & 9 RECEIVED
03/02/2019
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
29/09/2018
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
20/06/2016
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
20/06/2016
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
25/09/2015
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
25/09/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
24/09/2015
ES8R
TEAS SECTION 8 RECEIVED
14/09/2015
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/04/2010
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
29/09/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
25/08/2009
ALIE
ASSIGNED TO LIE
25/08/2009
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
20/08/2009
IUAA
USE AMENDMENT ACCEPTED
20/08/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/08/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/08/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/08/2009
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
04/08/2009
IUAF
USE AMENDMENT FILED
04/08/2009
EAAU
TEAS AMENDMENT OF USE RECEIVED
03/08/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/07/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/07/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
29/07/2009
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
03/02/2009
GNRT
NON-FINAL ACTION E-MAILED
03/02/2009
CNRT
NON-FINAL ACTION WRITTEN
03/02/2009
DOCK
ASSIGNED TO EXAMINER
27/01/2009
MPMK
NOTICE OF PSEUDO MARK MAILED
29/10/2008
NWAP
NEW APPLICATION ENTERED
28/10/2008
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BEAUFORT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.